Novavax (NVAX) Non-Current Deferred Revenue (2011 - 2026)
Novavax (NVAX) recorded Non-Current Deffered Revenue of $356.76 million in Q2 2026, down 10.6% from $399.26 million a year earlier and down 0.7% from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) Non-Current Deferred Revenue (2011 - 2026) Analysis & Trends
At the end of FY2025, Novavax reported Non-Current Deffered Revenue of $358.94 million, down 19.7% from FY2024.
- Annual Non-Current Deffered Revenue has a four-year compound annual growth rate of 20.1% (FY2021 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $446.82 million in FY2024 (-28.2%), $622.21 million in FY2023 (+246.8%), $179.41 million in FY2022 (+4.0%) and $172.5 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q1 2023.
- On a year-over-year basis, Non-Current Deffered Revenue has declined for nine consecutive quarters, with an average decline of 23.2% over the last eight quarters.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 246.8% in Q4 2023, against a decline of 51.3% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $359.27 million (Q1 2026), $358.94 million (Q4 2025) and $397.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Novavax | 1.80 Bn | -1.06 Bn | 44.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 330.01 Mn |
| Jun 30, 2026 | 356.76 Mn |
| Mar 31, 2026 | 359.27 Mn |
| Dec 31, 2025 | 358.94 Mn |
| Sep 30, 2025 | 397.11 Mn |
| Jun 30, 2025 | 399.26 Mn |
| Mar 31, 2025 | 409.56 Mn |
| Dec 31, 2024 | 446.82 Mn |
| Sep 30, 2024 | 515.37 Mn |
| Jun 30, 2024 | 533.43 Mn |
| Mar 31, 2024 | 841.47 Mn |
| Dec 31, 2023 | 622.21 Mn |
| Sep 30, 2023 | 608.84 Mn |
| Jun 30, 2023 | 606.94 Mn |
| Mar 31, 2023 | 274.06 Mn |
| Dec 31, 2022 | 179.41 Mn |
| Sep 30, 2022 | 1.04 Bn |
| Jun 30, 2022 | 814.63 Mn |
| Mar 31, 2022 | 441.75 Mn |
| Dec 31, 2021 | 172.50 Mn |
API Access
Novavax Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();